Why I Value Newsletters So Much

I'm a newsletter junkie...

I plow through more than a dozen advisories every month.

It all began when I went off to college and my dad signed me up with a gift subscription to the Washington D.C. insider report The Kiplinger Letter. I still receive that letter today.

So when I get a great question like this from a subscriber:

Dr. Eifrig, why do you recommend I subscribe to an "investment service" outside of Stansberry Research? Surely Stansberry, with all of the newsletters produced, has covered this investment path. If not, why not? – U.F.

I've got an easy answer...

Simply put, I love the business model of newsletters.

Unlike Wall Street, Stansberry Research and its analysts don't provide brokerage services or take banking fees. We simply sell our research to help subscribers like you make good decisions with your wealth and health. We get paid when you're happy. It's as simple as that.

Occasionally, I'll introduce you to some of our in-house analysts and their strategies. I know and work with these folks, and I have faith in their work... especially when it's outside my area of expertise. Getting information from several different sources is a valuable way to find the best investments.

More rarely, I'll find an opportunity outside of our usual Stansberry sphere with such potential and so unlike anything we're currently publishing, that I have to pass it on.

I especially like to alert you to ways to try research at no risk... when you can subscribe without any commitment. If you find that it's not for you, simply call in during your trial to receive all your money back.

[optin_form id="73"]

That's why I had to share a note today about one of the most successful stock analysts that I know in the newsletter business – Chris Mayer.

He recently opened up admission to an investment project he's been developing for the past few years. It's one I personally found so interesting, that I wanted (and offered!) to read his early letters before he released them to a wider audience.

I've followed Chris' work since 2004, and he's one of the best stock pickers in the game. Over the last decade, his stock selections have beaten almost everyone and everything... including Warren Buffett, David Einhorn, and Carl Icahn.

And his latest project is focusing on stocks that are simply too small for these major investors to buy... They're even too small for me to recommend in my Retirement Millionaire or Income Intelligence newsletters... even though they have big upside potential.

His ideal company is one with the potential to become a 100-bagger...

Perhaps you've heard of a "10-bagger" – a term popularized by Fidelity Magellan fund manager Peter Lynch. It's an investment that can return at least 10 times its initial purchase price...

Well, a single 100-bagger will turn every $10,000 you have to invest into $1 million. That's retire-early money.

Chris is looking for the "next Starbucks," the "next Google," and the "next Apple" before they turn up in the financial headlines... and before they begin to rally. And he doesn't just look at price charts or corporate filings...

Because these companies are so small, he has to research far beyond the norm to make sure that they're safe enough to hold for the long term as they grow:

  • He runs comprehensive background checks on the CFOs and CEOs...
  • Visits the companies for in-depth, boots-on-the-ground research...
  • Investigates their suppliers and competitors...

He even holds teleconference interviews with high-level executives from these companies each month – interviews that you can listen in on.

This is hedge-fund quality research on small companies with big potential.

For example, think of early investors in Internet megabrand Google (GOOG), computer and consumer-product maker Apple (AAPL), and medical-device maker Intuitive Surgical (ISRG). They picked the kinds of winners that you can retire on.

And I know firsthand the power of finding the type of stocks that make you feel like you've hit the lottery...

I've enjoyed speculating on biotech firms, including Amgen (AMGN) as it became the juggernaut that it is today, as well as a small private company that was sold to the pharmaceutical giant Roche.

Now, keep in mind that Chris doesn't take a "fast money" approach to trading. He's not going to recommend that you trade in and out of these companies. He's looking for high-quality, small companies that you can own as they grow at 20%-plus rates for years.

Think small companies that will turn into big companies... and hand investors massive returns in the process.

Chris has shown that the best way to make an exorbitant amount of money is to find great businesses at good prices and hold on to them for years.

Learn more about Chris' approach... and how you can receive a free year at no risk... by clicking here to watch his full presentation. (Or click here if you'd rather read a transcript.)

And if you're not 100% satisfied with what you receive within the first 30 days, Chris will refund 100% of your money. But this offer is only available until MIDNIGHT tonight. Again, full details here.

What We're Reading...

  • We'll announce the winners of our walking challenge in Friday's Q&A issue of Retirement Millionaire Daily.

Here's to our health, wealth, and a great retirement,

Dr. David Eifrig and the Retirement Millionaire Daily Research Team
February 7, 2017